스킵네비게이션

Enterprise Together with KSC

Company Overview
New drug development based on UIBR™ which is an integrated relational databases containing information of plant taxonomy, Traditional Chinese Medicine, modern medicine, pharmacology, and biochemistry with artificial intelligence-based genome analysis pipelines (GeIS™,MetaPre-AI™, Meta- ISM™, and Meta-Target™)

Sectors

  • Artificial Intelligence - Technology for analyzing plant genomes based on artificial intelligence algorithm

Project Summary

  • Development of new drugs via plant genome analysis with artificial intelligence-based bioinformatic pipelines

Business Model

  • Revenue model License out and royalty share through B2B collaborations or independent researches
  • Key CustomerGlobal pharmaceutical companies
Major Performance

  • Sales

    • USD 293K (2018), 270K (2019), 250K (2020)

  • Investment

    • USD 3.3M (PRE-A investment underway)

  • Employees

    • (2018) 18
    • (2019) 19
    • (2020) 15

  • Patent

    • 2 Registration, 7 Application, 11 Trade mark Registration
Overseas Expansion

Stage

Preparing for overseas expansion

Status

Try to enter markets of USA and India

Products / Services
1 2
Target Country
Finland
Date of Establishment
May 1, 2015
  • CEO
    Janghyuk Son Jongsun Park
  • Founder’s Background
    • Janghyuk Son
    • InfoBoss Inc., CEO (2016~)
    • Institute for Basic Science Exploration(Project-EARTH), Head of research center (2015~)
    • Korea University, M.D. Economics (2017)
    • Jongsun Park
    • InfoBoss Inc., CEO (2015~)
    • Stronghold Technology Inc., Korea, Head of research center (2013~2015)
    • Seoul Nat'l University, Ph.D. in Agricultural Biotechnology (Bioinformatics) (2010)
목록